Infancy onset hereditary spastic paraplegia associated with a novel atlastin mutation
This article has been corrected.
VIEW CORRECTIONGet full access to this article
View all available purchase options and get full access to this article.
Supplementary Material
File (e1.doc)
- Download
- 25.50 KB
References
1.
Mc Dermott CJ, White K, Bushby K, Shaw P. Hereditary spastic paraparesis: a review of new developments. J Neurol Neurosurg Psychiatry . 2000; 69: 150–160.
2.
Zhao X, Alvarado D, Rainier S, et al. Mutations in a newly defined GTPase gene cause autosomal dominant hereditary spastic paraplegia. Nat Genet . 2001; 29: 326–331.
3.
Muglia M, Magariello A, Nicoletti G, et al. Further evidence that SPG3A gene mutations cause autosomal dominant hereditary spastic paraplegia. Ann Neurol . 2002; 51: 794–795.
4.
Tessa A, Casali C, Damiano M, et al. An additional family carrying a new atlastin mutation. Neurology . 2002; 59: 2002–2005.
5.
Devon RS. At last—Atlastin provides new insight into spastic paraplegia. Clin Genet . 2002; 61: 257–262.
Information & Authors
Information
Published In
Copyright
© 2003.
Publication History
Received: December 12, 2002
Accepted: April 21, 2003
Published online: August 25, 2003
Published in issue: August 26, 2003
Authors
Metrics & Citations
Metrics
Citation information is sourced from Crossref Cited-by service.
Citations
Download Citations
If you have the appropriate software installed, you can download article citation data to the citation manager of your choice. Select your manager software from the list below and click Download.
Cited By
- Redefining cerebral palsies as a diverse group of neurodevelopmental disorders with genetic aetiology, Nature Reviews Neurology, 19, 9, (542-555), (2023).https://doi.org/10.1038/s41582-023-00847-6
- A novel insertion mutation in atlastin 1 is associated with spastic quadriplegia, increased membrane tethering, and aberrant conformational switching, Journal of Biological Chemistry, 298, 1, (101438), (2022).https://doi.org/10.1016/j.jbc.2021.101438
- Clinical features and genotype-phenotype correlation analysis in patients with ATL1 mutations: A literature reanalysis, Translational Neurodegeneration, 6, 1, (2017).https://doi.org/10.1186/s40035-017-0079-3
- Extremely Severe Complicated Spastic Paraplegia 3A With Neonatal Onset, Pediatric Neurology, 51, 5, (726-729), (2014).https://doi.org/10.1016/j.pediatrneurol.2014.07.027
- Hereditary spastic paraplegia: clinico-pathologic features and emerging molecular mechanisms, Acta Neuropathologica, 126, 3, (307-328), (2013).https://doi.org/10.1007/s00401-013-1115-8
- Hereditary Spastic Paraplegia, Emery and Rimoin's Principles and Practice of Medical Genetics, (1-54), (2013).https://doi.org/10.1016/B978-0-12-383834-6.00126-9
- Very Early Onset and Severe Complicated Phenotype Caused by a New Spastic Paraplegia 3A Gene Mutation, Journal of Child Neurology, 27, 10, (1348-1350), (2012).https://doi.org/10.1177/0883073811435245
- Motor neuron disease due to neuropathy target esterase gene mutation: Clinical features of the index families, Muscle & Nerve, 43, 1, (19-25), (2010).https://doi.org/10.1002/mus.21777
- Hereditary spastic paraplegia and axonal motor neuropathy caused by a novel SPG3A de novo mutation, Brain and Development, 32, 7, (592-594), (2010).https://doi.org/10.1016/j.braindev.2009.08.003
- Hereditary Spastic Paraplegia, Neurogenetics, (227-255), (2009).https://doi.org/10.1201/9780849358364.ch12
Loading...
View Options
Login options
Check if you have access through your login credentials or your institution to get full access on this article.
Personal login Institutional LoginPurchase Options
Purchase this article to access the full text.